period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.0,0.85,0.15000000000000002,0,0.15000000000000002,[1],
1,1.2,0.85,0.35,0,0.2916666666666667,[1],"The FDA is actively monitoring an emerging shortage situation. Stakeholders are encouraged to report any supply issues, and manufacturers should maintain open lines of communication with the FDA to facilitate potential coordination efforts."
2,1.2,0.9999999999999999,0.20000000000000007,0,0.16666666666666674,[1],The FDA is closely monitoring the emerging shortage and encourages manufacturers and distributors to report any supply disruptions. We are working with industry partners to ensure continuity of supply and minimize impact on patients.
3,1.2,0.9999999999999999,0.20000000000000007,0,0.16666666666666674,[1],The FDA is aware of the emerging shortage situation regarding the identified drug. We encourage manufacturers to provide updates on their production capacities and urge healthcare providers to report any impacts on patient care. Coordination efforts are being considered to address early signs of supply disruption.
